Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Third MVA-CMDR Boost in HIVIS03 Volunteers
NCT01461447Phase 2Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Mar 2012
- Primary completion
- May 2012
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-CMDR in human immunodeficiency virus infection (HIV), sponsored by Muhimbili University of Health and Allied Sciences. Started Mar 2012; status: completed.
02
Drugs
MVA-CMDR
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01461447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01461447.